Clotrimazole

Major

Clotrimazole Colchicine Colcrys Increased colchicine exposure and an increased risk of colchicine-related toxicity Details Clotrimazole Bedaquiline Sirturo Increased bedaquiline exposure Details Clotrimazole Alfentanil Increased ALfentanil exposure and an increased risk of respiratory depression Details Clotrimazole Dihydroergotamine Brekiya Increased ergot derivatives exposure and an increased risk of ergotism (nausea, vomiting, vasospastic ischemia) Details Clotrimazole Doxorubicin Adriamycin Increased doxorubicin exposure and an increased risk of doxorubicin-related adverse reactions Details Clotrimazole Doxorubicin Hydrochloride Liposome Increased doxorubicin exposure and an increased risk of doxorubicin-related adverse reactions Details Clotrimazole Ergoloid Mesylates Alkergot® Increased ergot derivatives exposure and an increased risk of ergotism (nausea, vomiting, vasospastic ischemia) Details Clotrimazole Ergonovine Increased ergot derivatives exposure and an increased risk of ergotism (nausea, vomiting, vasospastic ischemia) Details Clotrimazole Ergotamine Ergomar Increased ergot derivatives exposure and an increased risk of ergotism (nausea, vomiting, vasospastic ischemia) Details Clotrimazole Finerenone Kerendia Increased finerenone exposure and an increased risk of finerenone-related adverse effects Details Clotrimazole Haloperidol Increased haloperidol exposure and an increased risk of haloperidol-related adverse events, including QTc interval prolongation Details Clotrimazole Lemborexant Dayvigo Increased lemborexant exposure and an increased risk of lemborexant-related adverse reactions. Details Clotrimazole Lisuride Increased ergot derivatives exposure and an increased risk of ergotism (nausea, vomiting, vasospastic ischemia) Details Clotrimazole Lomitapide Increased lomitapide exposure Details Clotrimazole Loperamide Diamode Increased loperamide exposure and an increased risk of loperamide-related adverse reactions Details Clotrimazole Meperidine Demerol Increased meperidine exposure and risk of increased or prolonged opioid effects Details Clotrimazole Metergoline Increased ergot derivatives exposure and an increased risk of ergotism (nausea, vomiting, vasospastic ischemia) Details Clotrimazole Methylergonovine Methergine Increased ergot derivatives exposure and an increased risk of ergotism (nausea, vomiting, vasospastic ischemia) Details Clotrimazole Methysergide Increased ergot derivatives exposure and an increased risk of ergotism (nausea, vomiting, vasospastic ischemia) Details Clotrimazole Mifepristone Korlym Increased miFEPRIStone exposure Details Clotrimazole Nicergoline Increased ergot derivatives exposure and an increased risk of ergotism (nausea, vomiting, vasospastic ischemia) Details Clotrimazole Nifedipine Adalat® Increased NIFEdipine exposure Details Clotrimazole Paclitaxel Abraxane Increased PACLitaxel exposure Details Clotrimazole Paclitaxel Protein-Bound Increased PACLitaxel exposure Details Clotrimazole Pimozide Increased pimozide exposure Details Clotrimazole Roflumilast Daliresp Increased roflumilast exposure and an increased risk of roflumilast-related adverse events Details Clotrimazole Tacrolimus Astagraf Increased tacrolimus concentration and an increased risk of toxicity Details Clotrimazole Tramadol ConZip Increased traMADol exposure and an increased risk of seizures, serotonin syndrome and opioid toxicity Details Clotrimazole Voriconazole Vfend Increased voriconazole exposure and an increased risk of voriconazole-related adverse reaction Details Clotrimazole Dihydroergotamine Injection DHE-45® Injection Increased ergot derivatives exposure and an increased risk of ergotism (nausea, vomiting, vasospastic ischemia) Details Clotrimazole Dihydroergotamine Nasal Spray Migranal Increased ergot derivatives exposure and an increased risk of ergotism (nausea, vomiting, vasospastic ischemia) Details

Moderate

Clotrimazole Artemether Increased artemether/lumefantrine exposure and an increased risk of potentiated QT prolongation Details Clotrimazole Dofetilide Tikosyn Increased dofetilide exposure Details Clotrimazole Hydrocortisone Ala-Cort Increased hydrocortisone exposure and an increased risk of hydrocortisone-related adverse reactions Details Clotrimazole Lumefantrine Increased artemether/lumefantrine exposure and an increased risk of potentiated QT prolongation Details Clotrimazole Sirolimus Felycin An increased risk of sirolimus toxicity (anemia, leukopenia, thrombocytopenia, hypokalemia, fever, diarrhea) Details Clotrimazole Trimetrexate Increased trimetrexate toxicity (bone marrow suppression, renal and hepatic dysfunction, and gastrointestinal ulceration) Details Clotrimazole Hydrocortisone Injection A-Hydrocort® Increased hydrocortisone exposure and an increased risk of hydrocortisone-related adverse reactions Details